China Medical Technologies Gets China OK for EGFR Assay | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – China Medical Technologies today said that it has received regulatory approval from Chinese authorities to market its real-time PCR-based Epidermal Growth Factor Receptor assay as an aid in making treatment decisions for lung cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.